CCG is hosting a 1-day meeting focusing on benefits of computer-aided ligand and structure-based drug design techniques for medicinal chemists.
Short hands-on workshops in the morning will be followed by scientific presentations in the afternoon. The meeting will end with a social reception.
Please note that space is limited so early registration is recommended.
Registration (check-in and badge pick-up)
Pharmacophore Modeling / Docking / Fragment-based Design / Scaffold Replacement / R-Group Screening / Project Search / Protein-Ligand Interaction Fingerprints
R-Group Profiles and Analysis / MOEsaic / MMP Analysis / Descriptor Calculations / Conformational Searching / Molecular Alignments / Pharmacophore Modeling and Searching / Diversity Analysis
|13:00-13:25||Registration (check-in and badge pick-up)|
Andreas Goutopoulos, Senior Director- Chemistry, EMD Serono, Inc.
Matt Lucas, Director of Chemistry, Yumanity Therapeutics
Chris Yates, Director of Medicinal Chemistry, Viamet Pharmaceuticals
Al Ajamian, Director, Chemical Computing Group
Sean Brown, Principal Scientist, Amgen
Jörg Bentzien, Principal Scientist, FORMA Therapeutics, Inc.
Ravi Kurumbail, Research Fellow, Pfizer
Edward J. Hennessy, Associate Principal Scientist, AstraZeneca
There is no cost to attend but pre-registration is required as seats are limited. Registrations will be processed and accepted on a first-come, first-serve basis.